DNA for evaluating the progression potential of cervical lesions
AssigneeDeutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
InventorsMatthias Dürst, Matthias Nees
Life of this patent
Estimating the term…
Abstract
The present invention relates to a nucleic acid which is suitable for evaluating the progression potential of cervial lesions, wherein the nucleic acid is obtainable by a process in which RNA from early and late passages of HPV-immortalized cells is isolated and the RNAs characteristic for the early passages and late passages, respectively, are identified and provided as DNA or RNA. Furthermore, the present invention concerns polypeptides coded by such a nucleic acid. In addition, it covers antibodies directed against the polypeptides. Moreover, it relates to the use of the DNA and the polypeptides as well as a kit suitable for evaluating the progression of cervical lesions.
Claims4
An isolated nucleic acid molecule which encodes the protein encoded by SEQ ID NO:
- 1.
An isolated nucleic acid molecule useful in determining progression of a cervical lesion, comprising the nucleotide sequence of SEQ ID NO:
- 2.
A method for determining progression of a cervical lesion, comprising determining expression or level of expression of a nucleic acid molecule which either (i) encodes the protein encoded by the nucleotide sequence set forth in SEQ ID NO:
- 1, or (ii) comprises the nucleotide sequence of SEQ ID NO:
- 2, in a sample of HPV immortalized cells taken from said cervical lesion, and correlating said determination to a predetermined level of expression indicative of status of a cervial cancer lesion.
Dependencies are inferred from the claim text.